Although much exploration is still needed regarding ISM1 research, its roles in hematopoiesis, tumor immunity, diabetes, and nonalcoholic fatty liver disease have thus far been revealed, indicating the great therapeutic potential of ISM1. This evidence concerns the gene ISM1 and metabolic dysfunction-associated steatotic liver disease.